Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Combination eye therapy may cut injection frequency for vein occlusion patients

NCT ID NCT01295112

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 25 times

Summary

This study looked at whether adding Ozurdex to standard Avastin eye injections can reduce the number of injections needed for people with a blocked vein in the eye (non-ischemic central retinal vein occlusion). 68 adults participated. The main goal was to count how many Avastin injections were needed over 24 weeks, and also to check vision improvement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Texas Retina Associates

    Dallas, Texas, 75231, United States

Conditions

Explore the condition pages connected to this study.